Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aurinia Pharmaceuticals (GB:0UJF)
LSE:0UJF
RESEARCH TOOLSreports
Holding GB:0UJF?
Track your performance easily
Aurinia Pharmaceuticals (0UJF) Ownership Overview
2.76% Insiders
5.13% Mutual Funds
16.67% Other Institutional Investors
5.85% ETFs
69.59% Public Companies and
Individual Investors
The ownership structure of Aurinia Pharmaceuticals (GB:0UJF) stock is a mix of institutional, retail, and individual investors. Approximately 27.65% of the company’s stock is owned by Institutional Investors, 2.76% is owned by Insiders, and 69.59% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 08, 2024 | xxxxxxxxxxxxx | $96902 | |
| May 22, 2024 | Brinda Balakrishnan Director | xxxxxxxxxxxxx | $2985 |
| May 22, 2024 | David R.w. Jayne Director | xxxxxxxxxxxxx | $28390 |
| May 22, 2024 | Daniel Billen Director | xxxxxxxxxxxxx | $30146 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,115,321 | Institution | 4.28% | 68,717,862 | |
| 2,410,103 | Institution | 1.69% | 27,082,327 | |
| 1,599,331 | Institution | 1.12% | 17,971,682 | |
| 1,522,114 | Insider | 1.06% | 17,103,995 | |
| 1,175,614 | Institution | 0.82% | 13,210,375 | |
| 670,415 | Institution | 0.47% | 7,533,453 | |
| 639,029 | Institution | 0.45% | 7,180,769 | |
| 622,762 | Institution | 0.44% | 6,997,977 | |
| 584,072 | Insider | 0.41% | 6,563,217 | |
| 495,928 | Insider | 0.35% | 5,572,743 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,410,103 | Institution | 1.69% | 27,082,327 | |
| 1,599,331 | Institution | 1.12% | 17,971,682 | |
| 670,415 | Institution | 0.47% | 7,533,453 | |
| 639,029 | Institution | 0.45% | 7,180,769 | |
| 622,762 | Institution | 0.44% | 6,997,977 | |
| 461,585 | Institution | 0.32% | 5,186,831 | |
| 116,810 | Institution | 0.08% | 1,312,594 | |
| 83,656 | Institution | 0.06% | 940,042 | |
| 82,828 | Institution | 0.06% | 930,738 | |
| 82,593 | Institution | 0.06% | 928,098 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Aurinia Pharmaceuticals (GB:0UJF)?
According to the latest TipRanks data, approximately 16.67% of the company's stock is held by institutional investors, 2.76% is held by insiders, and 69.59% is held by retail investors.
What percentage of Aurinia Pharmaceuticals (GB:0UJF) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.67% of Aurinia Pharmaceuticals (GB:0UJF) stock is held by institutional investors.
What percentage of Aurinia Pharmaceuticals (GB:0UJF) stock is held by retail investors?
According to the latest TipRanks data, approximately 69.59% of Aurinia Pharmaceuticals (GB:0UJF) stock is held by retail investors.
Who owns the most shares of Aurinia Pharmaceuticals (GB:0UJF)?
iShares owns the most shares of Aurinia Pharmaceuticals (GB:0UJF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.